Catastrophic antiphospholipid syndrome: a narrative review

  • Maria Giulia Tinti Unit of Internal Medicine, ‘Casa Sollievo della Sofferenza’ Hospital, I.R.C.C.S., San Giovanni Rotondo (FG), Italy.
  • Vincenzo Carnevale Unit of Internal Medicine, ‘Casa Sollievo della Sofferenza’ Hospital, I.R.C.C.S., San Giovanni Rotondo (FG), Italy.
  • Angela De Matthaeis Unit of Internal Medicine, ‘Casa Sollievo della Sofferenza’ Hospital, I.R.C.C.S., San Giovanni Rotondo (FG), Italy.
  • Antonio Varriale Unit of Internal Medicine, ‘Casa Sollievo della Sofferenza’ Hospital, I.R.C.C.S., San Giovanni Rotondo (FG), Italy.
  • Angelo De Cata | angelo.decata@libero.it Unit of Internal Medicine, ‘Casa Sollievo della Sofferenza’ Hospital, I.R.C.C.S., San Giovanni Rotondo (FG), Italy.

Abstract

The catastrophic antiphospholipid syndrome (CAPS) is a lifethreatening disorder characterized by the rapid development of multiple organs/systems thrombosis, in patients with persistently detectable antiphospholipid antibodies. The vascular occlusions predominantly affect small vessels, leading to a disseminated thrombotic microangiopathic syndrome. Most CAPS episodes are related to the presence of a precipitating factor, such as infections and malignant diseases, usually ending up in multiple organ failure. Clinical manifestations may vary according to the extent of the thrombosis, predominantly affecting kidneys, lungs, brain, heart, and skin. Treatment is based on the administration of anticoagulants, corticosteroids, plasma exchange and/or intravenous immunoglobulins. Cyclophosphamide is recommended in CAPS associated with systemic lupus erythematosus. Additionally, rituximab and eculizumab have been used in refractory cases. Overall mortality is still 36.9%, despite recent progress in the therapeutic approach.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2019-12-20
Info
Issue
Section
Reviews
Keywords:
Catastrophic antiphospholipid syndrome, antiphospholipid antibodies, thrombosis, complement-activation.
Statistics
  • Abstract views: 468

  • PDF: 178
How to Cite
Tinti, M. G., Carnevale, V., De Matthaeis, A., Varriale, A., & De Cata, A. (2019). Catastrophic antiphospholipid syndrome: a narrative review. Beyond Rheumatology, 1(2), 47-51. https://doi.org/10.4081/br.2019.23